Navigating a time-sensitive cell therapy supply chain during the coronavirus outbreak
Why established systems and relationships matter
Subscribe
Get updates from the Cell Lines Blog delivered to your inbox.
Quality Starting Material: The Driving Force Behind Life-Saving Cell Therapies
By Jamie Margolis, PhD, SVP of Donor Services, NMDP/Be The Match®
Cell collection standards for cell therapies
A case study from the Standards Coordinating Body developed in partnership with Be The Match BioTherapies
How to overcome 3 common cell therapy supply chain disruptions
Design a tailored logistics plan to deliver
Overcoming challenges to cellular starting material collection
Q&A with the Be The Match BioTherapies Collection Network Liaison team
Driving CAR-T therapy safety and sustainability for the road ahead
Q&A with Abby McDonald, PhD, Solutions Development Supervisor
An opportunity to impact the future of medicine
As told by Leah, Be The Match BioTherapies® allogeneic donor